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Background: The thermophilic anaerobe Thermoanaerobacterium saccharolyticum is capable of directly fermenting
xylan and the biomass-derived sugars glucose, cellobiose, xylose, mannose, galactose and arabinose. It has been
metabolically engineered and developed as a biocatalyst for the production of ethanol.
Results: We report the initial characterization of the carbon catabolite repression system in this organism. We find
that sugar metabolism in T. saccharolyticum is regulated by histidine-containing protein HPr. We describe a
mutation in HPr, His15Asp, that leads to derepression of less-favored carbon source utilization.
Conclusion: Co-utilization of sugars can be achieved by mutation of HPr in T. saccharolyticum. Further manipulation
of CCR in this organism will be instrumental in achieving complete and rapid conversion of all available sugars to
ethanol.
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Metabolic yield is one of the most important factors in
determining economic feasibility for biological-based
conversion of biomass to fuels and chemicals. Most bac-
teria have evolved tailored carbon utilization pathways
and regulatory schemes for the uptake and catabolism of
carbon sources in their environment. The order in which
sugars are utilized is frequently determined by a mech-
anism known as carbon catabolite repression (CCR) [1].
CCR ensures that the cell’s energy expenditure on sugar
import and metabolism will be directed to the carbon
source that is most easily accessible and allows for fast-
est growth [2,3].
The firmicutes are low G+C, gram-positive bacteria
and include potential biofuel-producing species from the
classes Clostridia and Bacilli. Studies of CCR in firmi-
cutes have revealed the importance of the Histidine-
containing Protein HPr [3-5]. HPr(His15-P) donates a
phosphate to glucose imported via the phosphotransfer-
ase system (PTS). Histidine-dephosphorylated HPr is
then phosphorylated by HPr kinase (HPrK) at Ser46
[6-8] and this form of the protein mediates repression in* Correspondence: cherring@mascoma.com
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distribution, and reproduction in any mediumconcert with the transcriptional regulator Catabolite
Control Protein A (CcpA) [9]. In most firmicutes, His15
and Ser46 phosphorylation of HPr are mutually antagon-
istic [10,11]. Under conditions of nutrient limitation,
HPrK acts as a phosphorylase, removing the serine
phosphate of HPr and inhibiting CcpA-mediated gene
regulation [8]. A doubly phosphorylated form of HPr
has been detected in Bacillus subtilis under certain
growth conditions; this form of the protein was absent
or significantly reduced when strong CCR was induced
[12]. Some firmicutes additionally produce Crh (catabol-
ite repression HPr), a protein homologous to HPr but
lacking the His15 residue. Crh is involved in CcpA-
dependent CCR but plays no role in PTS function [13].
In Escherichia coli and other gram-negative enteric bac-
teria reviewed in [3,14], transcriptional regulation of
catabolic genes is mediated by the phosphorylation state
of the PTS EIIAGlc subunit and cAMP concentration,
not HPr [15,16].
We studied CCR in the firmicute Thermoanaerobac-
terium saccharolyticum, which consumes xylan and
other biomass-derived sugars to produce ethanol and a
mixture of organic acids [17]. Metabolic engineering has
redirected carbon flux almost exclusively to ethanol [18].
In order to develop this organism into an even morentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,




































C.                    Cellobiose and cAMP
Figure 1 cAMP-independent CCR by 2-deoxyglucose. (A) and
(B): Increasing amounts of 2-deoxyglucose were added to T.
saccharolyticum M2476 cultures supplemented with 5 g/L glucose or
cellobiose (black = 5 mg/L; green = 50 mg/L; blue = 0.5 g/L; red = 5
g/L 2-deoxyglucose). (C): cAMP and 2-deoxyglucose were added to
T. saccharolyticum M2476 cultures supplemented with 5 g/L
cellobiose (solid black = no additions; dashed black = 5 mM cAMP;
solid red = 5 g/L 2-deoxyglucose; dashed red = 5 mM cAMP and 5
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ively manipulate its carbon source utilization. T. sac-
charolyticum can grow on a wide spectrum of sugars,
and although it can co-utilize glucose and xylose, it exhi-
bits carbon source preferences when cultured in other
sugar mixtures. The molecular basis for these prefer-
ences is unknown. A study of the glycobiome of the
related Thermoanaerobacter sp. X514 revealed that glu-
cose and xylose utilization can occur in parallel and are
both regulated by transcriptional antiterminators of the
BglG family. Hexose and pentose co-utilization was
interpreted as absence of CCR in that organism [19]. In
the present study, we demonstrate the presence of CCR
in T. saccharolyticum. We identify homologs to all major
CCR genes and find that in T. saccharolyticum, CCR is
mediated by HPr phosphorylation. We characterize a
mutant of HPr that provides relief from CCR and we
discuss the possible mechanism by which the mutation
leads to the observed growth characteristics.
Results
cAMP-independent CCR in T. saccharolyticum
M2476, the parent strain used in this study, was derived
from the ethanologen strain M1442 [20] by deletion of the
perR gene. Deletion of perR upregulates the oxidative
stress response and improves oxygen tolerance [21] but is
not expected to influence CCR. The non-metabolizable
glucose analog 2-deoxyglucose has been used extensively
to induce catabolite repression in bacteria [22-27]. When
utilization of the sole carbon source in the medium is
repressed, growth is inhibited and CCR can be detected by
monitoring the culture optical density [23]. We added 2-
deoxyglucose to microwell cultures containing a single
sugar as the main carbon source. 2-deoxyglucose delayed
growth in cellobiose (Figure 1B) but not glucose cultures
(Figure 1A), indicating that 2-deoxyglucose led to CCR of
cellobiose utilization. Exogenous addition of cAMP provides
CCR relief in E. coli [28,29]. 5 mM cAMP had no effect on
the growth delay caused by 2-deoxyglucose (Figure 1C) sug-
gesting that in T. saccharolyticum, 2-deoxyglucose-induced
CCR is cAMP-independent.g/L 2-deoxyglucose).T. saccharolyticum CCR is mediated by HPr
A BLAST search of the T. saccharolyticum genome with
B. subtilis CCR genes showed significant matches for
HPr (E-value: 3 × 10-17), HPrK (1 × 10-85), Crh (9 × 10-24)
and CcpA (16 matches with E-values: 3x10-19-1 × 10-85)
suggesting that T. saccharolyticum uses the same ele-
ments of CCR as B. subtilis. To study the role of HPr in
T. saccharolyticum CCR, we replaced the endogenous
HPr gene in strain M2476 with a modified copy encod-
ing the histidine phosphomimetic HPr His15Asp to cre-
ate strain M2907. We reasoned that if HPr mediatesPTS import and CCR, the mutant strain would be com-
promised for PTS sugar import and exhibit resistance to
CCR. We evaluated growth of strains M2476 and
M2907 on glucose, xylose, mannose, galactose, arabinose
or cellobiose as the primary carbon source. Growth of
the mutant strain M2907 in all sugars tested (Figure 2,
dashed black lines) indicates that these sugars can be
imported independently of HPr as a PTS phosphate
donor. M2907 grew more slowly than M2476 on glu-



































































Figure 2 T. saccharolyticum CCR is relieved by HPr His15Asp. Cultures of strains M2476 (HPr, solid lines) and M2907 (HPr His15Asp, dashed
lines) supplemented with the indicated sugars were grown in the absence (black lines) or presence (red lines) of 5 g/L 2-deoxyglucose.
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its parent on xylose, galactose, arabinose and cellobiose
in the presence of 2-deoxyglucose (Figure 2, red lines)
suggesting that CCR of these sugars is relieved by the
HPr His15Asp mutation. While other ethanologen
strains of T. saccharolyticum grow well on galactose,
M2476 does not, which was confirmed in bottle cultures.
The HPr His15Asp mutation slightly improved growth
in galactose.
HPr His15Asp leads to altered order of sugar utilization
We next examined the effect of the HPr His15Asp mu-
tation on sugar utilization in a mixture of sugars. Experi-
ments were carried out in anaerobic bottles (data not
shown) and fermentors (Figure 3) with similar results.
When arabinose was the primary carbon source, M2476
and M2907 consumed arabinose at a similar rate and
depleted it from the medium by 20 hours (Figure 3A). In
a mixture of glucose and arabinose, M2476 preferentially
consumed glucose within the first 20 hours and had only
consumed 50% of the arabinose by 60 hours (Figure 3B,filled symbols). The M2907 mutant showed complete
reversal of sugar preference: arabinose was utilized at
the same rate as when it was supplied alone and
glucose was only partially utilized by 60 hours
(Figure 3B, open symbols). A strain carrying muta-
tions in HPr at positions 45 and 46 was unable to
grow on arabinose (Additional file 1).
When the same strains were grown in a mixture of
glucose, arabinose, galactose, mannose and xylose,
M2907 again demonstrated an altered sugar utilization
profile (Figure 4). Galactose and arabinose consumption
was clearly derepressed and was complete by 60 hours.
Glucose utilization was significantly slower in the mu-
tant (Figure 4A) in agreement with the previous experi-
ment (Figure 3B). Mannose and xylose utilization
presented a more complex phenotype. Both these sugars
were consumed in the presence of glucose by the wild-
type strain (Figure 4B). Consumption of mannose was
largely inhibited in strain M2907. In contrast, xylose was
































B. Arabinose and Glucose
A. Arabinose
Figure 3 HPr His15Asp mutation enables arabinose utilization
in the presence of glucose. The level of glucose (triangles) and
arabinose (squares) remaining in the culture medium was
determined for cultures of T. saccharolyticum strains M2476 (HPr,
filled symbols) and M2907 (HPr His15Asp, open symbols)






























Figure 4 HPr His15Asp mutation alters the order of sugar
utilization. The level of sugar remaining in the culture medium was
determined for cultures of T. saccharolyticum strains (A) M2476 and
(B) M2907 supplemented with glucose, arabinose, xylose, galactose
and mannose, as indicated.
Tsakraklides et al. Biotechnology for Biofuels 2012, 5:85 Page 4 of 7
http://www.biotechnologyforbiofuels.com/content/5/1/85Discussion
The ability of T. saccharolyticum to ferment biomass-
derived sugars at elevated temperature renders it an at-
tractive biocatalyst for the production of fuels and re-
newable chemicals. We investigated carbon catabolite
repression in this organism to better understand sugar
utilization and how to manipulate it. Sequence hom-
ology and our experimental data indicate that T. sac-
charolyticum CCR is regulated by HPr in a mechanism
similar to that of the model organism B. subtilis. We
have identified orthologues to all the major elements in
the B. subtilis pathway: HPr, HPrK, Crh and CcpA. HPr-
mediated CCR is emerging as a shared feature of the
firmicute phylum with evidence of its presence in all fir-
micutes studied to date [3].
In our experiments, the HPr His15Asp mutation led
to relief of 2-deoxyglucose-induced repression for mul-
tiple sugars and allowed for arabinose and galactose
utilization in the presence of glucose. We speculate that
HPr His15Asp leads to CCR relief through lowering glu-
cose/2-deoxyglucose import and preventing CcpA acti-
vation. Lack of a donor phosphate to transfer from HPr(His-P) to the PTS EIIAGlc subunit is expected to lead to
reduced PTS function and therefore limit any down-
stream repressive effects of glucose import. In Listeria
monocytogenes, a His15Ala or His15Asp HPr mutation
leads to reduction of HPr PTS activity by more than
96% [30]. Consistent with this result, M2907 grew more
slowly on glucose (Figure 2) and consumed glucose at a
slower rate (Figures 3 and 4). Reduced glucose import
may therefore be responsible for CCR relief in the
histidine-substituted HPr mutant strain. HPr His15Asp
may also provide relief from CCR by directly preventing
CcpA activity. The antagonistic relationship of Ser46
and His15 phosphorylation opens the possibility that the
histidine phosphomimetic mutant blocks serine phos-
phorylation of HPr [11] and therefore prevents activa-
tion of CcpA by HPr(Ser-P). In vitro evidence has shown
that Streptococcus salivarius and L. monocytogenes HPr
(His15-P) or its phosphomimetic variant HPr(His15Asp)
can be phosphorylated at the serine position [30,31] and
a doubly phosphorylated form of HPr has been detected
in B. subtilis [12]. However, the level of doubly phos-
phorylated HPr is reduced under CCR [12] and doubly
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likely because unphosphorylated His15 contributes to
HPr-CcpA binding directly and phosphorylation at
His15 blocks CcpA activation by disrupting this inter-
action [32]. The phosphomimetic mutant HPr His15Asp
reported here is therefore expected to disrupt HPr-CcpA
interaction and block downstream CcpA-mediated re-
pression. Whether by controlling intracellular concentra-
tion of the catabolite repressor or the activity of CcpA,
HPr is clearly a major regulator of CCR in T.
saccharolyticum.
Growth of the mutant strain in all sugars tested sug-
gests that phosphate transfer from HPr(His-P) is not es-
sential in the metabolism of glucose, xylose, mannose,
galactose, arabinose and cellobiose. The T. saccharolyti-
cum genome annotation predicts that arabinose and xy-
lose are likely transported by ABC-type transporters
rather than the PTS. We have identified putative ortho-
logues of GlcU and GlkA, a glucose importer and gluco-
kinase [34-37], as candidates for non-PTS glucose
transport.
Although growth on mannose and xylose was repress-
ible by 2-deoxyglucose (Figure 2), both these sugars were
consumed by the wild-type T. saccharolyticum strain
inoculated in medium containing glucose (Figure 4B),
suggesting that glucose affects the utilization of these
sugars to a lesser extent. Whereas the non-metabolizable
2-deoxyglucose effectively shuts down their metabolism,
glucose is a consumable repressor and its intracellular
concentration may be lower. Alternatively, cells actively
growing on glucose may contain metabolic intermediates
that lessen CCR of xylose and mannose. Supporting this,
consumption of xylose and mannose quickly followed
after an initial reduction of glucose in the medium, fol-
lowed by significant overlap in utilization of all three
sugars. In the HPr His15Asp strain, xylose was com-
pletely consumed at a slower rate than in the wild-type
strain but at a similar rate to arabinose and cellobiose.
Mannose utilization was very poor in the HPr His15Asp
strain, suggesting that it is likely transported by the same
or similar PTS components as for glucose. The data
show three groups of sugars with similar CCR and
utilization profiles: 1) glucose and mannose - both
dependent on phosphoryl transfer at His15 of HPr;
2) xylose – affected to some degree by CCR but partly in-
dependent; and 3) arabinose and galactose – both appar-
ently utilized best when HPr / PTS function is blocked.
HPr has also been implicated in pathway-specific acti-
vation or repression. Lactobacillus brevis HPr(Ser-P)
inactivates lactose and galactose permease [38,39].
Reduced serine phosphorylation due to a phosphomi-
metic histidine mutation is therefore expected to relieve
repression of these sugars. In Streptococcus thermophi-
lus, HPr(His-P) is required for activation of lactosetransport through activating phosphorylation of the lac-
tose permease [40]. When glucose is present and
imported by the PTS, phosphate is diverted to glucose
preventing activation of lactose import. As the HPr
His15Asp mutant is unable to donate a phosphate, any
such sugar import pathways requiring phosphate trans-
fer from HPr(His-P) will remain inactive. Study of HPr
interactions with sugar permeases is required to estab-
lish whether it plays such sugar-specific roles in T.
saccharolyticum.
Although derepressed for arabinose and galactose
utilization in the presence of glucose, the HPr His15Asp
strain was not able to co-utilize all five sugars present in
biomass efficiently because of a detrimental effect of the
HPr mutation on glucose and mannose utilization. It
should be possible to overcome this limitation by selec-
tion for spontaneous glucose and mannose utilizing iso-
lates [41]. Alternatively, expression of heterologous
high-capacity transporters or manipulation of native
transporters may serve to decouple preferred-sugar
transport and CCR.
Conclusions
Preferential utilization of carbon sources offers a select-
ive advantage in nature where bacteria compete for
resources [2,3] but hinders industrial applications where
metabolic yield and productivity determine economic
feasibility. Understanding the components and effectors
of CCR is critical to the development of biocatalysts
with expanded carbon source utilization profiles [42]. In
the present study, we have begun to characterize the
molecular basis of CCR in T. saccharolyticum. We found
that T. saccharolyticum CCR is mediated by HPr and
used our findings to construct a CCR derepressed strain.
Further study and manipulation of T. saccharolyticum
CCR should enable the engineering of strains that co-
utilize mixed sugars to achieve increased metabolic yield
and wider feedstock utilization.
Methods
Strains and media
M2476, the parent strain used in this study, was derived
from the ethanologen strain M1442 [20] by deletion of
the perR gene (Tsac_2491 in T. saccharolyticum genome
[GenBank: CP003184]) using previously described meth-
ods [43-45]. We replaced the endogenous HPr gene in
strain M2476 with a modified copy encoding the HPr
His15Asp mutant using a previously described method
for genomic integration [44] to create strain M2907. All
growth experiments were conducted in TSC7 medium
(per liter: 8.5 g yeast extract, 1 g trisodium citrate*2H2O,
1 g KH2PO4, 2 g MgSO4*7H2O, 1.85 g (NH4)2SO4, 0.2 g
CaCl2*2H2O, 0.2 g FeSO4*7H2O, 0.12 g Methionine, 0.5
g L-Cysteine HCl, pH 5.8) supplemented with the sugars
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Although T. saccharolyticum can utilize yeast extract as
a carbon source, the amount contained in TSC7 is not
sufficient to attain the optical densities observed in these
assays without the addition of a sugar carbon source.2-deoxyglucose-induced repression assays
For 2-deoxyglucose titration, a range of 0.005 – 5.0 g/L
2-deoxyglucose and 5 mM cAMP (Sigma-Aldrich, St.
Louis, MO) were added as indicated to T. saccharolyti-
cum microwell cultures supplemented with 5 g/L glu-
cose or cellobiose, inoculated with 10% v/v of an
exponentially growing culture in the same medium (one
of three replicate experiments is presented in Figure 1).
To determine the effect of HPr His15Asp mutation on
2-deoxyglucose-induced CCR, microwell cultures sup-
plemented with 10 g/L glucose, xylose, mannose, galact-
ose, arabinose or cellobiose were inoculated with 10% v/
v exponentially growing culture of M2476 or M2907
(one of two replicates is shown in Figure 2). Growth
curves were obtained by measuring absorbance at 600
nm in a BioTek PowerWaveXS plate reader with inter-
mittent agitation, inside a COY laboratories anaerobic
chamber with a nominal atmosphere of 85% N2, 10%
CO2, 5% H2.Sugar co-utilization tests
Experiments were carried out in anaerobic bottles (data
not shown) and fermentors (Figure 3) with similar
results. Sartorius Biostat Aplus fermentors at 1 liter
working volume were sparged with 95% N2, 5% CO2 gas
prior to inoculation with 5% v/v overnight culture grown
in the same medium. Agitation was at 150 rpm and the
pH was maintained at 5.8 with NH4OH. Sugars in the
culture medium were analyzed by HPLC using a BioRad
Aminex HPX-87P column and a refractive index de-
tector. For the two-sugar fermentations, glucose, arabin-
ose or both sugars were added to a final concentration
of 20 g/L each in TSC7 medium. For the five-sugar fer-
mentations, glucose, arabinose, galactose, mannose and
xylose were added to a final concentration of 10 g/L
each in TSC7 medium.Additional file
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